Radiology researchers have developed and validated an automated program for tracking incidental imaging findings. The system facilitates communications between radiologists, patients and primary care providers whenever such findings turn up.  

A federal judge also halted the order, which instructed federal agencies to “temporarily pause all activities related to obligation or disbursement of all federal financial assistance."

If approved, the two agents could offer providers greater insight into the process of patients’ neurodegeneration.

Melissa Davis, MD, vice chair of medical informatics and associate professor at Yale University’s Department of Radiology and Biomedical Imaging, shares her findings from research on private equity market penetration.

Systole Health is focused on providing personalized healthcare to women with heart disease. “As a cardiologist, I have witnessed firsthand the struggles women face in managing their heart health," the company's co-founder said.

This is the week of DeepSeek. 

Founded in 2019, Evergreen develops and manufactures imaging agents aimed at diagnosing and treating cancer, including Octevy for neuroendocrine tumors. 

The Spain-based company offers a suite of solutions to aid in interpreting MRI, CT, and PET scans, boasting 170 installations across the globe.